Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: An evaluation by a randomized double-blinded trial

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 1, 2005, Pages 79-83

  Nielsen, Viveque Egsgaard ^a   Bonnema, Steen Joop ^a   Boel Jørgensen, Henrik ^a   Veje, Annegrete ^a   Hegedüs, Laszlo ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RECOMBINANT THYROTROPIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG INHIBITION; FEMALE; HUMAN; IODINE 131 UPTAKE TEST; MAJOR CLINICAL STUDY; MALE; NODULAR GOITER; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; THYROID GLAND;

ADULT; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; GOITER, NODULAR; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIATION DOSAGE; RECOMBINANT PROTEINS; THYROTROPIN;

EID: 12244283717     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1550     Document Type: Article

References (22)

1. Bonnema SJ, Bennedbæk FN, Wiersinga WM, Hegedüs L 2000 Management of the nontoxic multinodular goitre: a European questionnaire study. Clin Endocrinol (Oxf) 53:5-12
2. Bonnema SJ, Bennedbaek FN, Ladenson PW, Hegedüs L 2002 Management of the nontoxic multinodular goiter: a North American survey. J Clin Endocrinol Metab 87:112-117
3. Hegedüs L, Bonnema SJ, Bennedbæk FN 2003 Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102-132
4. Hegedüs L, Hansen BM, Knudsen N, Hansen JM 1988 Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goiter. BMJ 297: 661-662
5. Le Moli R, Wesche MF, Tiel-van Buul MM, Wiersinga WM 1999 Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goiter. Clin Endocrinol (Oxf) 50:783-789
6. Nygaard B, Hegedüs L, Gervil M, Hjalgrim H, Soe-Jensen P, Hansen JM 1993 Radioiodine treatment of multinodular non-toxic goitre. BMJ 307:828-832
7. Van Isselt JW, de Klerk JM, Koppeschaar HP, Van Rijk PP 2000 Iodine-131 uptake and turnover rate vary over short intervals in Graves' disease. Nucl Med Commun 21:609-616
8. Traino AC, Di Martino F, Lazzeri M, Stabin MG 2000 Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism. Phys Med Biol 45:121-129
9. Duick DS, Baskin HJ 2003 Utility of recombinant human thyrotropin for augmentation of radioiodine uptake and treatment of nontoxic and toxic multinodular goiters. Endocr Pract 9:204-209
10. Huysmans DA, Nieuwlaat WA, Erdtsieck RJ Schellekens AP, Bus JW, Bravenboer B, Hermus AR 2000 Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter. J Clin Endocrinol Metab 85:3592-3596
11. Torres MS, Ramirez L, Simkin PH, Braverman LE, Emerson CH 2001 Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects. J Clin Endocrinol Metab 86:1660-1664
12. Nieuwlaat WA, Hermus AR, Sivro-Prndelj F, Corstens FH, Huysmans DA 2001 Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. J Clin Endocrinol Metab 86:5330-5336
13. de Klerk JM, Van Isselt JW, van Dijk A, Hakman ME, Pameijer FA, Koppeschaar HPF, Zelissen PMJ, Van Schaik JPJ, Van Rijk PP 1997 Iodine-131 therapy in sporadic nontoxic goiter. J Nucl Med 38:372-376
14. Nieuwlaat WA, Hermus AR, Ross HA, Buijs WC, Edelbroek MA, Bus JW, Corstens FH, Huysmans DA 2004 Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone. J Nucl Med 45:626-633
15. Hegedüs L, Perrild H, Poulsen LR, Andersen JR, Holm B, Schnohr P, Jensen G, Hansen JM 1983 The determination of thyroid volume by ultrasound and its relation to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab 56:260-263
16. Bonnema SJ, Andersen PB, Knudsen DU, Hegedüs L 2002 MR imaging of large multinodular goiters: observer agreement on volume versus observer disagreement on dimensions of the involved trachea. AJR Am J Roentgenol 179:259-266
17. Silva MNC, Rubio IGS, Romao R, Gebrin EMMS, Buchpiguel C, Tomimori E, Camargo R, Cardia MS, Medeiros-Neto G 2003 Administration of a single dose of recombinant human thyrotropin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Clin Endocrinol (Oxf) 59:1-9
18. Catargi B, Leprat F, Guyot M, Valli N, Ducassou D, Tabarin A 1999 Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and of other possible factors affecting outcome. Eur J Endocrinol 141:117-121
19. Berg GE, Michanek AM, Holmberg EC, Fink M 1996 Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements. J Nucl Med 37:228-232
20. Nieuwlaat WA, Huysmans DA, van den Bosch HC, Sweep CG, Ross HA, Corstens FH, Hermus AR 2003 Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 88:3121-3129
21. Nielsen VE, Bonnema SJ, Hegedüs L, The effects of recombinant human thyrotropin, in normal subjects and patients with goitre: a review. Clin Endocrinol (Oxf), in press
22. Nielsen VE, Bonnema SJ, Hegedüs L 2004 Effects of 0.9 mg recombinant human thyrotropin on thyroid size and function in normal subjects: a randomized, double-blind, cross-over trial. J Clin Endocrinol Metab 89:2242-2247